TP53 and ovarian carcinoma: Recent studies have shown that inhibition of DNA methylation by chemicals such as 5-aza-2′-deoxycytidine significantly induced antitumor immune responses in colon and ovarian cancers [9, 10] and resulted in cell cycle arrest, p53-dependent apoptosis, and IFN signaling activation of HPV-positive HNC cells [30].